Cargando…
Metabolic Aspects of Anthracycline Cardiotoxicity
Heart failure (HF) is increasingly recognized as the major complication of chemotherapy regimens. Despite the development of modern targeted therapies such as monoclonal antibodies, doxorubicin (DOXO), one of the most cardiotoxic anticancer agents, still remains the treatment of choice for several s...
Autores principales: | Russo, Michele, Della Sala, Angela, Tocchetti, Carlo Gabriele, Porporato, Paolo Ettore, Ghigo, Alessandra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7864817/ https://www.ncbi.nlm.nih.gov/pubmed/33547494 http://dx.doi.org/10.1007/s11864-020-00812-1 |
Ejemplares similares
-
Advanced Imaging Modalities to Monitor for Cardiotoxicity
por: Seraphim, Andreas, et al.
Publicado: (2019) -
Cardiotoxicities of 5-Fluorouracil and Other Fluoropyrimidines
por: Shiga, Taro, et al.
Publicado: (2020) -
Advances in the Treatment of Cardiac Amyloidosis
por: Macedo, Ariane Vieira Scarlatelli, et al.
Publicado: (2020) -
Cardiovascular Toxicities of Androgen Deprivation Therapy
por: Challa, Azariyas A., et al.
Publicado: (2021) -
Cardio-oncology Training in the COVID-19 Era
por: Feldman, Stephanie, et al.
Publicado: (2021)